Efficacy and safety of subcutaneous L-dopa/carbidopa (ND0612H) infusion in fluctuating PD patients

被引：0

作者：

Olanow, C. Warren ^{[1
]}

Stocchi, Fabrizio ^{[2
,3
]}

Poewe, Werner ^{[4
]}

Ellenbogen, Aaron ^{[5
,6
]}

Djaldetti, Ruth ^{[7
]}

Minei, Tami Rachmilewitz ^{[8
]}

Cohen, Yael ^{[8
]}

Oren, Sheila ^{[8
]}

Kieburtz, Karl ^{[9
]}

机构：

[1] Mt Sinai Med Ctr, New York, NY 10029 USA

[2] Univ Rome, Rome, Italy

[3] IRCCS San Raffaele Roma, Rome, Italy

[4] Univ Hosp Neurol, Innsbruck, Austria

[5] Michigan Inst Neurol Disorders, Farmington Hills, CT USA

[6] Quest Res Inst, Farmington Hills, CT USA

[7] Tel Aviv Univ, Petah Tiqwa, Israel

[8] NeuroDerm, Rehovot, Israel

[9] Univ Rochester, Med Ctr, Rochester, NY 14642 USA

来源：

NEUROLOGY | 2018年 / 90卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

S26.003

引用

页数：3

共 27 条

[21] Efficacy and Safety of Standardized Extract of Trigonella foenum-graecum L Seeds as an Adjuvant to L-Dopa in the Management of Patients with Parkinson's Disease
Nathan, J.
Panjwani, Siddika
Mohan, V.
Joshi, Veena
Thakurdesai, Prasad Arvind
PHYTOTHERAPY RESEARCH, 2014, 28 (02) : 172 - 178
[22] Safety and efficacy of continuous subcutaneous levodopa-carbidopa infusion (ND0612) for Parkinson's disease with motor fluctuations (BouNDless): a phase 3, randomised, double-blind, double-dummy, multicentre trial (vol 43, pg 465, 2024)
Espay, A. J.
Stocchi, F.
Pahwa, R.
LANCET NEUROLOGY, 2024, 23 (06) : E10 - E10
[23] BouNDless: An active-controlled, randomised, double-blind, double-dummy trial of continuous subcutaneous infusion of levodopa/carbidopa with ND0612 in patients with Parkinson's disease experiencing motor complications
Rascol, O.
Poewe, W.
Stocchi, F.
Yardeni, T.
Adar, L.
Rosenfeld, O.
Olanow, C.
EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 1105 - 1105
[24] Efficacy and safety of safinamide as an add-on therapy to L-DOPA for patients with Parkinson's disease: A randomized, double-blind, placebo-controlled, phase II/III study
Hattori, Nobutaka
Tsuboi, Yoshio
Yamamoto, Akihiko
Sasagawa, Yuji
Nomoto, Masahiro
PARKINSONISM & RELATED DISORDERS, 2020, 75 : 17 - 23
[25] A six-month multicentre, double-blind, bromocriptine-controlled study of the safety and efficacy of ropinirole in the treatment of patients with Parkinson's disease not optimally controlled by L-dopa
Brunt, ER
Brooks, DJ
Korczyn, AD
Montastruc, JL
Stocchi, F
JOURNAL OF NEURAL TRANSMISSION, 2002, 109 (04) : 489 - 502
[26] A six-month multicentre, double-blind, bromocriptine-controlled study of the safety and efficacy of ropinirole in the treatment of patients with Parkinson's disease not optimally controlled by l-dopa
E. R. Brunt
D. J. Brooks
A. D. Korczyn
J.-L. Montastruc
F. Stocchi
Journal of Neural Transmission, 2002, 109 : 489 - 501
[27] A 6-week, double-blind, multicenter RCT in Parkinson's disease patients to explore the efficacy and safety of AFQ056 when combined with increased doses of L-dopa
Kumar, R.
Hauser, R. A.
Mostillo, J.
Dronamraju, N.
Graf, A.
Merschhemke, M.
MOVEMENT DISORDERS, 2012, 27 : S126 - S126

← 1 2 3 →